International experts discuss how to achieve the waiver for monopolies on COVID-19 products
September 15, 2021: MSF organsied this information forum on the temporary waiver on monopolies for COVID-19 products, featuring
- Sara Matthieu, Group of the Greens/ European Free Alliance, MEP Belgium
- Ro Khanna, Congressman, U.S. House of Representatives
- Joseph E. Stiglitz, Nobel Laureate Economist, Professor, Columbia University
- Graham Dutfield, Professor of International Governance, School of Law, University of Leeds
- Siva Thambisetty, Associate Professor of Law, London School of Economics and Political Science
Member of the European Parliament Sara Matthieu called the position of the European Commission a blatant disrespect of democracy and the Parliament, adding that its position was unacceptable.
Congressman Ro Khanna said that the waiver has to extend to therapeutics and that President Biden has to convince Europe to live up to their moral responsibility.
Prof. Stiglitz stressed that we're not putting a good face on democracy when we say our democracies put profits over lives. He stressed that there's no doubt that intellectual property is one of the bottlenecks that has to be removed and it's the one thing that the market can't do.
Dr. Siva called the EU’s proposal “performative” for it states the obvious and does not change the current rules.
Prof. Dutfied explained how during the Second World War the US played an important role in ensuring sharing of know-how and how Pfizer has benefited from the sharing of this know-how to become a major corporation.
You can watch and listen on the YouTube link here.